Effects of Binaural Beats and Spatialized Music on Behavioural and Psychological Symptoms of Dementia in Assisted Living Facility Residents

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-95
SponsorMaharishi International University

About this trial

The purpose of this study is to investigate the effects of Binaural Beat Music (BBM; personalized music playlist with binaural beats), Spatialized Music (SM; personalized and spatialized music playlist), their combination, and possible interaction on older adults in an assisted living community who are either living with a dementia diagnosis or are experiencing typical age-related changes. The control condition is a personalized music playlist without binaural beats and spatialization. It is hypothesized that BBM, SM, and their combination each improve aspects of BPSD compared to controls over a two-week intervention period.

The Specific Aims of the study are (1) to evaluate whether BBM, SM, and/or their combination is superior to control in reducing BPSD severity (primary outcome); (2) to evaluate whether BBM, SM, and/or their combination is superior to control in reducing caregiver distress (secondary outcomes); and (3) to evaluate the effects of BBM, SM, and/or their combination on improving overall well-being and mood (secondary outcomes).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

(1) age 55-95 years; (2) the subject and/or his/her legal guardian have signed written informed consent; (3) the subject is able to complete the entire trial period; and (4) a minimum of fifty percent of the subjects will have a diagnosis of a dementia condition with a moderate to severe progression.

Disqualifiers

(1) profound hearing loss or impairment; (2) history of seizures, epilepsy (especially sound-induced epilepsy), claustrophobia, or other conditions that put the subject at risk during the trial; (3) physical or mental conditions that may result in inability to complete and/or affect the efficacy of assessment.

Trial design

Design model

Factorial

Treatments tested in this trial

  • Personalized Music Listening (PML)

    Other intervention

    A personlized music playlist is generated by an audio workstation based on text prompts describing prominent musical features for a chosen favourite genre and style. For each entry in the music playlist, acoustic features are extracted from the audio waveforms and higher-level perceptual features are derived that correlate with human emotional and physiological responses to music. A music playlist with a total duration of ±20 minutes is generated for each individual session based on the derived higher-level perceptual features. The selection and slope of a music playlist is adjusted for the time of day by considering the progression of extracted audio features, i.e., an upward slope to increase arousal for morning sessions (AM) and a downward slope to induce a calming effect for afternoon sessions (PM). PML sessions are administered using wireless noise-cancelling headphones and take place in a quiet room with comfortable seating for groups of up to 10 subjects at a time.

  • Binaural Beat Music (BBM)

    Other intervention

    BBM is the combination of pure tones with a variable carrier frequency embedded in the music playlist recordings. The carrier frequency is adaptive to the music it is combined with. A fixed 10 Hz difference between the carrier frequencies of the left and right headphone channels produces a perceived binaural beat frequency corresponding to an alpha brain-wave pattern associated with relaxation.

  • Spatialized Music (SM)

    Other intervention

    SM is the presentation of the music playlist such that vocal and instrumental stems are perceived as reverberating within a virtual space from different angles and positions relative to the subject. The music recordings are modified and rendered as a spatialized version using acoustic simulation software.

Treatment groups

120 Participants
are divided into 4 treatment groups
Group A: B0S0Sham comparator 1 intervention
Group B: B1S0Active comparator 2 interventions
Group C: B0S1Active comparator 2 interventions
Group D: B1S1Active comparator 3 interventions

Trial outcomes

Primary outcomes

1

BPSD Severity - assessed by the Neuropsychiatric Inventory Questionnaire (NPI-Q)

The NPI-Q is consists of a 12-item questionnaire and assesses a broad range of psychiatric disturbances associated with: (1) delusions; (2) hallucinations; (3) agitation or aggression; (4) depression or dysphoria; (5) anxiety; (6) elation or euphoria; (7) apathy or indifference; (8) disinhibition; (9) irritability or lability; (10) motor disturbance; (11) nighttime behaviors; and (12) appetite and eating. Each item is scored whether it is present, and if so, how severe it is on a 3-point scale. Total scores as well as item scores are assessed. A reduction of 3 or more points on the total score indicated clionically meaningful improvement.

Time frame
Before the start and after completion of a 2 week treatment

Secondary outcomes

1

Caregiver Distress - assessed by the Neuropsychiatric Inventory Questionnaire (NPI-Q)

The NPI-Q assesses the distress to the caregiver on a 6-point scale for each item. To the extent that the interventions are effective in relieving behavioral and emotional problems in patients, these changes may in turn affect the well-being of their caregivers.

Time frame
Before the start and after completion of a 2 week treatment
2

Subjective Well-being - assessed by the WHO-5

The 5-item World Health Organization Well-Being Index (WHO-5) is used assessing subjective psychological well-being. A raw score from 0 to 25 is multiplied by 4 to create a 0-100 score, where higher scores indicate better well-being. A score of 50 or below indicates poor mental well-being and suggests the need for further evaluation. A score of 28 or below strongly indicates likely depression. A clinically relevant change in the WHO-5 Well-Being Index is generally defined as a 10-point difference (or more) on the 0-100 scale. This shift reliably indicates that an individual's psychological well-being has meaningfully improved or deteriorated.

Time frame
Before the start and after completion of a 2 week treatment
3

Subjective Mood - assessed by Emoji Mood Scales (EMS)

EMS is a validated, ultra-brief measure of mood and current experience, with minimal literacy demands on participants. For this study, we administer an emoji-ordinal scale with 3 categories: (1) unhappy emoji: frowning face (unicode U+2639); (2) neutral emoji: neutral face (U+1F610); and (3) happy emoji: smiling face (U+1F642). In addition to EMS measures, investigators will note any comments, phrases, and vocalizations from the subject.

Time frame
Before and after each 20 minute music sessions, for 14 days consecutively.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Maharishi International University

Lead sponsor

Music in the Space Between LLC

Collaborator

CoroHealth LLC

Collaborator

Hollie Kemp Consulting LLC

Collaborator

Oxford Health Group LLC

Collaborator